IMGN901

DRUG2 trials

Sponsors

ImmunoGen, Inc.

Conditions

Multiple MyelomaSmall Cell Lung Cancer

Phase 1

IMGN901 in Combination With Lenalidomide and Dexamethasone

CompletedNCT00991562

ImmunoGen, Inc.Multiple Myeloma

Start: 2009-12-31End: 2014-10-31Target: 50Updated: 2014-11-21

A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

TerminatedNCT01237678

ImmunoGen, Inc.Small Cell Lung Cancer

Start: 2010-11-30End: 2015-05-31Updated: 2018-01-18